Effect of sleep restriction therapy in patients with insomnia disorder comorbid to Parkinson's disease

SHI Yan; WANG Yuanyuan; LIU Xuedong; BAI Ya; MA Lei; LI Wen

doi:10.7619/jcmp.20214395

Journal of Clinical Medicine in Practice > 2021 > 25(23): 49-52. > DOI: 10.7619/jcmp.20214395

SHI Yan, WANG Yuanyuan, LIU Xuedong, BAI Ya, MA Lei, LI Wen. Effect of sleep restriction therapy in patients with insomnia disorder comorbid to Parkinson's disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 49-52. DOI: 10.7619/jcmp.20214395

Citation:

PDF (604 KB)

Effect of sleep restriction therapy in patients with insomnia disorder comorbid to Parkinson's disease

1.
Department of Neurology, the First Affiliated Hospital of Air Force Military Medical University of the Chinese People's Liberation Army, Xi'an, Shaanxi, 710032
2.
Department of Neurology, Xi'an Qinhuang Hospital of Shaanxi Province, Xi'an, Shaanxi, 710000

More Information

Received Date: November 07, 2021
Available Online: December 20, 2021
Published Date: December 14, 2021

Graphical Abstract

Abstract

Abstract

Objective To observe the effects of sleep restriction therapy (SRT) in patients withinsomnia disorder comorbid to Parkinson's disease.
Methods A total of 90 patients with insomnia disorder comorbid to Parkinson's disease were recruited in the study, 4 cases withdrew or lost in follow-up, and 86 cases were finally completed the study. They were randomly divided into treatment group and control group, with 43 cases in each group. Besides the sleep health education, the sleep restriction therapy was given in the treatment group. The control group only received sleep health education and was followed up weekly by telephone or Internet. Pittsburgh sleep quality index (PSQI), Epworth Sleepiness Scale (ESS), Parkinson's disease rating scale Part 3 (UPDRS-Ⅲ), Hamilton Anxiety Rating Scale (HAMA), Hamilton Depression Rating Scale (HAMD) and 36-item Shot-form Health Status Survey (SF-36) were used to evaluate the sleep status, motor symptoms, emotional state and quality of life of the patients.
Results The total effective rate of two groups showed a significant difference(P < 0.05). After intervention, there were statistically significant differences in PSQI, ESS, HAMA and HAMD scores between the two groups (P < 0.05). After intervention, the patients in the observation group scored (73.86±6.57) in SF-36, which was higher than (45.21±7.31) of the control group (P < 0.05).
Conclusion Sleep restriction therapy has high operability, and is easy to learn, master and popularize. It can improve sleep quality, emotional state and life quality of patients with insomnia disorder comorbid to Parkinson's disease.
- Parkinson's disease,
- sleep restriction therapy,
- insomnia disorder,
- quality of life

FullText(HTML)

References (17)

References

[1]	ZHANG Z X, ROMAN G C, HONG Z, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai[J]. Lancet, 2005, 365(9459): 595-597. doi: 10.1016/S0140-6736(05)70801-1
[2]	LEBRUN C, GÉLY-NARGEOT M C, BAYARD S. Insomnia comorbid to Parkinson's disease Part I: Epidemiology, assessment, and related factors[J]. Geriatr Psychol Neuropsychiatr Vieil, 2020, 18(3): 321-330. http://www.researchgate.net/publication/343264012_Insomnia_comorbid_to_Parkinson's_disease_Part_I_Epidemiology_assessment_and_related_factors
[3]	刘春风, 沈赟. 重视帕金森病睡眠障碍的规范管理[J]. 中华神经科杂志, 2019, 52(5): 361-363. doi: 10.3760/cma.j.issn.1006-7876.2019.05.001
[4]	李星, 梁红敏, 朱梅, 等. 超声引导下星状神经节阻滞治疗失眠症疗效和安全性评价[J]. 昆明医科大学学报, 2017, 38(4): 84-87. doi: 10.3969/j.issn.1003-4706.2017.04.021
[5]	MILLER C B, ESPIE C A, EPSTEIN D R, et al. The evidence base of sleep restriction therapy for treating insomnia disorder[J]. Sleep Med Rev, 2014, 18(5): 415-424. doi: 10.1016/j.smrv.2014.01.006
[6]	中华医学会神经病学分会, 中华医学会神经病学分会睡眠障碍学组. 中国成人失眠诊断与治疗指南(2017版)[J]. 中华神经科杂志, 2018, 51(5): 324-335. doi: 10.3760/cma.j.issn.1006-7876.2018.05.002
[7]	中华医学会神经病学分会帕金森病及运动障碍学组. 帕金森病的诊断标准(2016版)[J]. 中华神经科杂志, 2016, 49(4): 268-271. doi: 10.3760/cma.j.issn.1006-7876.2016.04.002
[8]	高阳. 大柴胡汤治疗失眠症(肝郁化火证)的临床疗效研究[D]. 长春: 长春中医药大学, 2017.
[9]	张丽, 朱骏, 蒋旭, 等. 基于量表的帕金森病睡眠障碍的发生率及临床特点分析[J]. 实用老年医学, 2020, 34(7): 5-5. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLA202007013.htm
[10]	王治东, 孙文华, 马建军, 等. 帕金森病患者睡眠障碍与精神症状相关性研究[J]. 中国神经精神疾病杂志, 2021, 47(2): 78-82. doi: 10.3969/j.issn.1002-0152.2021.02.003
[11]	WALLACE D M, WOHLGEMUTH W K, TROTTI L M, et al. Practical Evaluation and Management of Insomnia in Parkinson's Disease: A Review[J]. Mov Disord Clin Pract, 2020, 7(3): 250-266. doi: 10.1002/mdc3.12899
[12]	QASEEM A, KANSAGARA D, FORCIEA M A, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American college of physicians[J]. Ann Intern Med, 2016, 165(2): 125-133. doi: 10.7326/M15-2175
[13]	王继辉, 温盛霖, 胡三红. 简要行为疗法对慢性失眠患者体力活动的影响[J]. 中国神经精神疾病杂志, 2013, 39(9): 538-542. doi: 10.3969/j.issn.1002-0152.2013.09.006
[14]	HUMBERT M, FINDLEY J, HERNANDEZ-CON M, et al. Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series[J]. NPJ Parkinsons Dis, 2017, 3: 25. doi: 10.1038/s41531-017-0027-z
[15]	LEBRUN C, GÉLY-NARGEOT MC, ROSSIGNOL A, et al. Efficacy of cognitive behavioral therapy for insomnia comorbid to Parkinson's disease: A focus on psychological and daytime functioning with a single-case design with multiple baselines[J]. J Clin Psychol, 2020, 76(3): 356-376. doi: 10.1002/jclp.22883
[16]	蒋晓江, 郝凤仪, 陈南西, 等. 慢性失眠症的团体认知行为疗法[J]. 2017, 25(1): 112-118.
[17]	肖敏, 黄金, 赵雪. 认知行为疗法在成人慢性失眠中的应用现状[J]. 护理研究, 2018, 32(16): 2514-2517. doi: 10.12102/j.issn.1009-6493.2018.16.007

[1]	YAO Binbin, SHEN Yan, YANG Hongli, FENG Sujuan, HUANG Huaxing, ZHU Xueling, SHEN Lianglan. Impact of serum cystatin C and hypersensitivity C-reactive protein on the 3-year survival of patients undergoing maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 68-75, 80. DOI: 10.7619/jcmp.20240283
[2]	QIU Yuan, LI Li, ZENG Laixing. Changes of C reactive protein and serum procalcitoninin patients with severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 62-64. DOI: 10.7619/jcmp.201912018
[3]	MENG Xiangzhong, WEI Feng, WANG Na, SHI Zhenhua, DING Dongrui. Clinical analysis of plasma procalcitonin and C-reactive protein levels in 65 patients with septic shock[J]. Journal of Clinical Medicine in Practice, 2018, (3): 120-122. DOI: 10.7619/jcmp.201803035
[4]	LIU Li, LIU Mingxin, NIU Shihui, LU Zejun, WANG Nana, ZHANG Ling. Effect of irbesartan combined with atorvastatin on C reactive protein and cystatin C of patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2017, (21): 33-35. DOI: 10.7619/jcmp.201721009
[5]	ZHANG Shihui, ZHANG Yan, TANG Xi. Effects of hemodialysis combined with hemoperfusion on expression of β2-microglobulin and high-sensitivity C-reactive protein in patients with uremia[J]. Journal of Clinical Medicine in Practice, 2017, (5): 65-67. DOI: 10.7619/jcmp.201705018
[6]	LI Zhi. Changes and diagnostic value of serum procalcitonin and C-reactive protein in patients with severe infection in ICU[J]. Journal of Clinical Medicine in Practice, 2016, (5): 70-72. DOI: 10.7619/jcmp.201605021
[7]	LIU Chijia, CUI Yuntao, ZHANG Aimin. Change and significance of serum procalcitonin and C-reactive protein levels in cerebral hemorrhage patients complicated with infection[J]. Journal of Clinical Medicine in Practice, 2015, (13): 27-29. DOI: 10.7619/jcmp.201513008
[8]	XU Bin, FAN Zhigang, YANG Yun, XU Zongxian. Application of serum procalcitonin and C-reactive protein detections in the diagnosis of neonatal severe infectious disease[J]. Journal of Clinical Medicine in Practice, 2014, (24): 50-52. DOI: 10.7619/jcmp.201424015
[9]	YU Yanhua, LI Junrong, HOU Zhuoran. Influence of atorvastatin on serum visfatin,high-sensitivity C-reactive protein and nitric oxide in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2014, (23): 5-7. DOI: 10.7619/jcmp.201423002
[10]	ZHOU Lihua. Clinical significance of C-reactive protein and immunoglobulin in cerebrospinal fluid for children infected with meningitis[J]. Journal of Clinical Medicine in Practice, 2013, (16): 123-124,130. DOI: 10.7619/jcmp.201316048

Cited By

Cited by

Periodical cited type(2)

1.	于琪力，葛雪，刘丽. 冠状动脉粥样硬化性心脏病患者心力衰竭危险因素分析. 新乡医学院学报. 2024(06): 560-565 .
2.	孙宁，李飞. 心肌梗死患者血清miR-34a-5p和C1q/肿瘤坏死因子相关蛋白-9水平及其与心肌重构的相关性. 检验医学与临床. 2024(19): 2785-2789 .

Other cited types(0)

Get Citation

PDF

XML

Article views (315) PDF downloads (19) Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Effect of sleep restriction therapy in patients with insomnia disorder comorbid to Parkinson's disease

Abstract

References

Related Articles

Cited by

Periodical cited type(2)

Other cited types(0)

Catalog

Effect of sleep restriction therapy in patients with insomnia disorder comorbid to Parkinson's disease

Abstract

References

Related Articles

Cited by

Periodical cited type(2)

Other cited types(0)

Catalog

Export File

Citation

Format

Content